Chart calendar Gracell Biotechnologies Inc.
Upcoming events on Gracell Biotechnologies Inc.
Past events on Gracell Biotechnologies Inc.
2024-02-19 01:00 am | Extraordinary Shareholders Meeting |
2023-12-11 07:45 pm | American Society of Hematology Meeting - Abstract number: #1022 |
2023-11-29 09:35 am | Evercore ISI HealthCONx Conference |
2023-11-28 05:00 pm | Cell Therapy for Autoimmune Disease Summit |
2023-11-28 12:00 pm | Piper Sandler Healthcare Conference |
2023-11-15 06:30 am | Jefferies London Healthcare Conference |
2023-11-14 01:15 pm | Stifel Healthcare Conference |
2023-11-13 08:00 am | Q3 2023 Earnings Call |
2023-11-13 07:30 am | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number 248 |
2023-09-27 09:10 am | Cantor Global Healthcare Conference |
2023-09-27 06:30 am | International Myeloma Society Meeting - Abstract number : P-136 |
2023-09-26 09:00 am | Jefferies Cell & Genetic Medicine Summit |
2023-09-20 10:15 am | Stifel Immunology & Inflammation Virtual Summit |
2023-09-07 01:50 pm | Citi BioPharma Conference |
2023-09-06 01:30 pm | Wells Fargo Healthcare Conference |
2023-08-14 08:00 am | Q2 2023 Earnings Call |
2023-08-14 07:15 am | Q2 2023 Earnings Release |
2023-08-08 11:00 am | BTIG Virtual Biotechnology Conference |
2023-06-26 | Truist Securities Cell Therapy Symposium |
Past sector events for Gracell Biotechnologies Inc.
2024-05-10 07:00 am | HUMACYTE, INC.: Q1 2024 Earnings Release |
2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:10 pm | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | HILLEVAX, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |